Contents: Introduction to tuberculosis clinical trials and M. tuberculosis typing
Understanding mixed infections and their impact on clinical trials
How to distinguish relapse from reinfection and to determine emergent resistant strains
How to establish such methods in the context of trials
outlining the challenges that are still to be overcome.